Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort for vascular inflammation in patients at risk for atherosclerotic disease
NL-OMON25109Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of hydrocortisone in atherosclerosis (2 arms), sponsored by Academic Medical Center. Primary endpoint: Change in atherosclerotic plaque inflammation. Started Sep 2011; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NL-OMON25109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25109.